These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23855464)

  • 1. Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.
    Tomé-Carneiro J; Gonzálvez M; Larrosa M; Yáñez-Gascón MJ; García-Almagro FJ; Ruiz-Ros JA; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Ann N Y Acad Sci; 2013 Jul; 1290():37-51. PubMed ID: 23855464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.
    Tomé-Carneiro J; Gonzálvez M; Larrosa M; Yáñez-Gascón MJ; García-Almagro FJ; Ruiz-Ros JA; García-Conesa MT; Tomás-Barberán FA; Espín JC
    Am J Cardiol; 2012 Aug; 110(3):356-63. PubMed ID: 22520621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pig as a valuable model for testing the effect of resveratrol to prevent cardiovascular disease.
    Elmadhun NY; Sabe AA; Robich MP; Chu LM; Lassaletta AD; Sellke FW
    Ann N Y Acad Sci; 2013 Jul; 1290():130-5. PubMed ID: 23855475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.
    Tomé-Carneiro J; Gonzálvez M; Larrosa M; García-Almagro FJ; Avilés-Plaza F; Parra S; Yáñez-Gascón MJ; Ruiz-Ros JA; García-Conesa MT; Tomás-Barberán FA; Espín JC
    Mol Nutr Food Res; 2012 May; 56(5):810-21. PubMed ID: 22648627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for cardiovascular disease prevention.
    Gupta R; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):15-34. PubMed ID: 21257098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on 'resveratrol commonly displays hormesis: occurrence and biomedical significance' by Calabrese et al.
    Das DK
    Hum Exp Toxicol; 2010 Dec; 29(12):1016-7. PubMed ID: 21115560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus.
    Srikanth S; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):47-70. PubMed ID: 21257100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular protective effects of resveratrol.
    Bradamante S; Barenghi L; Villa A
    Cardiovasc Drug Rev; 2004; 22(3):169-88. PubMed ID: 15492766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grapes, wines, resveratrol, and heart health.
    Bertelli AA; Das DK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):468-76. PubMed ID: 19770673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol and health--a comprehensive review of human clinical trials.
    Smoliga JM; Baur JA; Hausenblas HA
    Mol Nutr Food Res; 2011 Aug; 55(8):1129-41. PubMed ID: 21688389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk management in community-dwelling elderly: opportunities for prevention.
    Ligthart SA; Richard E; van Gool WA; Moll van Charante EP
    Eur J Prev Cardiol; 2012 Dec; 19(6):1365-72. PubMed ID: 21930719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is new for resveratrol? Is a new set of recommendations necessary?
    Vang O
    Ann N Y Acad Sci; 2013 Jul; 1290():1-11. PubMed ID: 23855460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease.
    Tomé-Carneiro J; Gonzálvez M; Larrosa M; Yáñez-Gascón MJ; García-Almagro FJ; Ruiz-Ros JA; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):37-48. PubMed ID: 23224687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
    Lardizabal JA; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):87-103. PubMed ID: 21257102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol, in its natural combination in whole grape, for health promotion and disease management.
    Singh CK; Liu X; Ahmad N
    Ann N Y Acad Sci; 2015 Aug; 1348(1):150-60. PubMed ID: 26099945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heart of the matter: reducing CVD risk.
    Hayman LL; Kamau MW; Stuart-Shor EM
    Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396
    [No Abstract]   [Full Text] [Related]  

  • 17. A dietary resveratrol-rich grape extract prevents the developing of atherosclerotic lesions in the aorta of pigs fed an atherogenic diet.
    Azorín-Ortuño M; Yañéz-Gascón MJ; Pallarés FJ; Rivera J; González-Sarrías A; Larrosa M; Vallejo F; García-Conesa MT; Tomás-Barberán F; Espín JC
    J Agric Food Chem; 2012 Jun; 60(22):5609-20. PubMed ID: 22594392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and secondary prevention of cardiovascular disease: is there a place for Internet-based interventions?
    Pietrzak E; Cotea C; Pullman S
    J Cardiopulm Rehabil Prev; 2014; 34(5):303-17. PubMed ID: 25079147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-atherogenic effects of resveratrol.
    Ramprasath VR; Jones PJ
    Eur J Clin Nutr; 2010 Jul; 64(7):660-8. PubMed ID: 20485301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.